Oncosec Medical Inc
ONCSDelisted Jul 10, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001444307
Oncosec Medical Inc was delisted on Jul 10, 2023; its insiders filed their last Form 4 on Feb 9, 2023; 23 institutions reported holding it in 13F filings for Q3 2022, worth $2.51M in total; no superinvestor held it.
Key figures
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 23
- Q3 2022, −3 vs. previous quarter
- 13F value
- $2.51M
- Reported value at the end of Q3 2022
- Superinvestors holding
- 0
- At the end of Q3 2022
Superinvestors holding ONCS, Q3 2022
No superinvestor reported holding ONCS at the end of Q3 2022.
Latest insider trades
Open-market purchases and sales by Oncosec Medical Inc insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 9, 2023 (view filing) | Feb 9 | Same day | DelAversano Robert JVP, Finance | SSale | −40 | $1.37 | −$54.8 | −3.8%1.01K after | |
| Nov 4, 2022 (view filing)8:21 PM ET | Nov 4 | Same day | DelAversano Robert JVP, Finance | SSale | −283 | $0.37 | −$104.71 | −1.2%23.0K after | |
| Aug 5, 2022 (view filing) | Aug 5 | Same day | DelAversano Robert JVP, Finance | SSale | −284 | $0.71 | −$201.64 | −1.2%23.3K after | |
| May 6, 2022 (view filing) | May 6 | Same day | DelAversano Robert JVP, Finance | SSale | −274 | $0.83 | −$227.42 | −1.2%23.5K after | |
| Feb 11, 2022 (view filing) | Feb 9 | 2 days | DelAversano Robert JVP, Finance | SSale | −409 | $0.88 | −$359.92 | −1.7%23.8K after | |
| Nov 3, 2021 (view filing) | Nov 1 | 2 days | DelAversano Robert JVP, Finance | SSale | −343 | $1.75 | −$600.25 | −1.4%24.2K after | |
| Aug 25, 2021 (view filing) | Aug 23 | 2 days | Dalesandro MargaretDirector | PPurchase | +20.0K | $1.89 | +$37.8K | New position20.0K after | |
| Aug 24, 2021 (view filing) | Aug 20-23 | 4 days | Zhao YuhangDirector | PPurchase | +12.0K | $1.92 | +$23.0K | New position12.0K after | 2 lots |
| Aug 3, 2021 (view filing) | Aug 2 | 1 day | DelAversano Robert JVP, Finance | SSale | −412 | $2.18 | −$898.16 | −1.6%24.6K after |
Top 10 13F holders, Q3 2022
The largest institutional positions in Oncosec Medical Inc at the end of Q3 2022; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Avidity Partners Management LP | 2,945,000 | $1.44M | 0.03% | 00.0% | Unchanged |
| Vanguard Group Inc | 717,486 | $350.0K | 0.00% | −14,030−1.9% | Reduced |
| Bank of New York Mellon Corp | 383,491 | $187.0K | 0.00% | 00.0% | Unchanged |
| Salzhauer Michael | 296,282 | $145.0K | 0.09% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 274,196 | $133.0K | 0.00% | +1,944+0.7% | Added |
| Tocqueville Asset Management L.P. | 75,500 | $37.0K | 0.00% | +1,000+1.3% | Added |
| Long Focus Capital Management, LLC | 69,226 | $34.0K | 0.01% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 67,398 | $33.0K | 0.00% | −5,500−7.5% | Reduced |
| Susquehanna International Group, LLP | 62,229 | $30.0K | 0.00% | +13,759+28.4% | Added |
| State Street Corp | 43,729 | $21.0K | 0.00% | 00.0% | Unchanged |